HCPCS Code C9077

Injection, cabotegravir and rilpivirine, 2mg/3mg
Code effective Oct 01, 2021

HCPCS Section
Temporary Codes for Use with Outpatient Prospective Payment System

C9077 is a valid 2026 HCPCS code meaning Injection, cabotegravir and rilpivirine, 2mg/3mg or (Inj cabotegravir/rilpivirine) for short. HCPCS C9077 has been effective since 10/01/2021 and applies to Other medical items or services.

HCPCS Code Details - C9077

HCPCS Level II Code
Section C - Temporary Codes for Use with Outpatient Prospective Payment System
HCPCS Code C9077
Description

Long description:
Injection, cabotegravir and rilpivirine, 2mg/3mg

Short description:
Inj cabotegravir/rilpivirine

HCPCS Pricing indicator 53 - Statute
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Statute number 1833(t)
Coverage code D - Special coverage instructions apply
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 9 - Other medical items or services
Effective date Effective Oct 01, 2021
Date added Added Jul 01, 2021
Termination date Sep 30, 2021

See also

  • HCPCS C9076 · Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

  • HCPCS J0741 · Injection, cabotegravir and rilpivirine, 2mg/3mg

  • HCPCS C9078 · Injection, trilaciclib, 1 mg

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.